California Puts $21 Million Behind 112 Overdose-Fighting Groups

California is routing more than $21 million through 112 community organizations over the next twelve months to hand out naloxone, run prevention education and walk people into treatment, the Newsom administration announced Friday. The awards come from the Department of Health Care Services' Opioid and Stimulant Use Disorder Prevention and Education Program and cover Sept. 1, 2026 through Aug. 31, 2027, financed by the state's fourth State Opioid Response grant from the federal Substance Abuse and Mental Health Services Administration.

The release frames the money as a bet on trust rather than on a new clinical model: the organizations being paid are the ones already known in the neighborhoods where overdoses concentrate.

What the organizations are actually contracted to do

The scope is broad by design. Grantees will run outreach and education campaigns about opioid and stimulant risk, distribute naloxone and train people to use it, host workshops and town halls co-designed with community leaders, and provide peer navigation and screening that ends with what the department calls "direct personal introductions" to treatment and recovery supports. Several categories of partnership are written into the program — with health care and behavioral health providers, schools, tribes, faith-based groups and overdose prevention organizations — to strengthen referral pathways.

One line in the release points at a different kind of spending than the prevention language suggests. Grantees are also expected to pursue "innovative approaches that increase access to prevention and treatment resources for populations disproportionately affected by substance use," a category that in past rounds has covered everything from mobile outreach to culturally specific programming.

The service numbers the state is citing

Alongside the announcement, the department published counts from the program's prior year, September 2024 through September 2025: 28,109 patients received opioid use disorder treatment services; 6,713 received treatment for stimulant use disorder; 24,274 received recovery supports such as recovery housing, peer coaching, employment help and case management; and 14,090 new patients started medication for opioid use disorder. An estimated 164,349 people received prevention education, including 11,029 school-aged youth.

Those are the department's own service tallies for the previous round, not an evaluation of the organizations now being funded, and the release offers no comparison group against which to read them. Read side by side, they describe a program whose prevention reach is much wider than its clinical one: 164,349 people in prevention education against 28,109 who received opioid use disorder treatment and 14,090 who started medication.

"These investments empower local partners to meet people where they are, reduce stigma, and open doors to vital services," DHCS Director Michelle Baass said in the release. "When communities have the tools to educate, engage, and navigate people to treatment and recovery, we make measurable progress against opioid and stimulant harms."

Why stimulants share the program's name

The title of the program is itself a policy artifact. Federal State Opioid Response grants were opened to stimulant use disorder after Congress changed the funding's allowable uses in 2019, and states have since redirected a growing share of the money toward methamphetamine and cocaine — a shift that in Hawaii became a public dispute over whether opioid settlement dollars were being spent on a methamphetamine problem. California's program name puts both drug classes on equal footing, and the release's figures show stimulant treatment running at about a quarter of the opioid treatment caseload.

The state's separate supply-side work is mentioned in the same document. California sells CalRx-branded over-the-counter naloxone at what it describes as a significantly lower price, and its Naloxone Distribution Project has supplied kits that the state says have reversed more than 460,000 overdoses, a cumulative figure that spans the program's full history rather than the new grant year.

What the announcement leaves out

There is no list of the 112 awards, so it is not possible to tell from the release which organizations received how much, or whether the money is weighted toward the counties with the highest overdose death rates. Divided evenly, the $21 million would come to under $190,000 per organization — arithmetic the release does not perform, and a figure that would leave little room for clinical staffing at any single site.

Nor does the release set outcome targets for the new term. The prior year's counts are outputs, not results: the number of people who started medication says nothing about whether they stayed on it, and the number who received recovery supports says nothing about housing at the end of it. The department's own long-running programs for medication access — SB 184's requirement that treatment facilities offer medication or refer, the Tribal MAT Project, the hub-and-spoke network — are cited as context rather than as measures.

The structural question is the calendar. These are one-year awards, as the previous rounds were, which means the 112 organizations will be back at the same starting line next fall, competing for a fifth round of federal money that has not yet been appropriated. Community groups that hire outreach workers on twelve-month contracts carry that uncertainty into every hiring decision, and the neighborhoods where naloxone distribution matters most are not served by organizations that dissolve between grant cycles.

People looking for medication treatment can search medication-assisted treatment programs and naloxone access points regardless of which organization holds the current contract.